Blog

Tyler Dylan-Hyde Sells 15000 Shares of Crispr Therapeutics AG (CRSP) Stock – The Ledger Gazette


Dispatch Tribunal

Tyler Dylan-Hyde Sells 15000 Shares of Crispr Therapeutics AG (CRSP) Stock
The Ledger Gazette
Crispr Therapeutics logo Crispr Therapeutics AG (NASDAQ:CRSP) insider Tyler Dylan-Hyde sold 15,000 shares of Crispr Therapeutics stock in a transaction that occurred on Friday, December 15th. The shares were sold at an average price of $18.90, for a
Crispr Therapeutics' (CRSP) Hold Rating Reiterated at CannThe Lincolnian Online


Crispr Therapeutics (NASDAQ:CRSP) Research Coverage Started at OppenheimerStockNewsTimes
A Look at 2 Trending Stocks: CRISPR Therapeutics AG (CRSP), Athersys, Inc. (ATHX)Post Analyst
Dispatch Tribunal
all 14 news articles »

2017-12-21 NEWS
About Michael Zand

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.